Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
CODE BIO
Fourth Extension - Granted
Show more
Pharmaceutical and therapeutic preparations in the nature of adaptable, targetable, titratable, and re-dosable medicines for use in gene therapy, gene editing, and gene silencing; pharmaceutical preparations for the treatment of genetic diseases and disorders
Class 5 – Pharmaceuticals & supplements
Status timeline
- 13 Apr 2023Application filedNew Application Entered
- 5 Jan 2024Assigned to an examining attorneyAssigned To Examiner
- 5 Jan 2024Office action issuedNon-Final Action Written
- 29 Mar 2024Response to office action filedTeas Response To Office Action Received
- 1 Apr 2024Approved for publicationApproved For Pub - Principal Register
- 7 May 2024Published for oppositionPublished For Opposition
- 2 Jul 2024Notice of allowance issued — statement of use requiredNoa Mailed - Sou Required From Applicant
- 20 Dec 2024Statement-of-use extension 1 grantedSou Extension 1 Granted
- 17 Jun 2025Statement-of-use extension 2 grantedSou Extension 2 Granted
- 8 Dec 2025Statement-of-use extension 3 grantedSou Extension 3 Granted
All 44 events
| 2026-06-03 | Notice Of Approval Of Extension Request E-Mailed |
| 2026-06-02 | Sou Teas Extension Received |
| 2026-06-02 | Sou Extension 4 Filed |
| 2026-06-02 | Sou Extension 4 Granted |
| 2025-12-09 | Notice Of Approval Of Extension Request E-Mailed |
| 2025-12-08 | Sou Teas Extension Received |
| 2025-12-08 | Sou Extension 3 Filed |
| 2025-12-08 | Sou Extension 3 Granted |
| 2025-06-18 | Notice Of Approval Of Extension Request E-Mailed |
| 2025-06-17 | Sou Teas Extension Received |
| 2025-06-17 | Sou Extension 2 Filed |
| 2025-06-17 | Sou Extension 2 Granted |
| 2025-03-03 | Notice Of Approval Of Extension Request E-Mailed |
| 2024-12-20 | Sou Teas Extension Received |
| 2024-12-20 | Sou Extension 1 Filed |
| 2024-12-20 | Sou Extension 1 Granted |
| 2024-12-02 | Teas Change Of Owner Address Received |
| 2024-12-02 | Applicant/Correspondence Changes (Non-Responsive) Entered |
| 2024-12-02 | Teas Revoke/App/Change Addr Of Atty/Dom Rep Received |
| 2024-12-02 | Attorney/Dom.rep.revoked And/Or Appointed |
| 2024-12-02 | Teas Change Of Correspondence Received |
| 2024-07-02 | Noa Mailed - Sou Required From Applicant |
| 2024-05-07 | Published For Opposition |
| 2024-05-07 | Official Gazette Publication Confirmation E-Mailed |
| 2024-04-17 | Notification Of Notice Of Publication E-Mailed |
| 2024-04-01 | Approved For Pub - Principal Register |
| 2024-03-29 | Teas Response To Office Action Received |
| 2024-03-29 | Correspondence Received In Law Office |
| 2024-03-29 | Teas/Email Correspondence Entered |
| 2024-01-05 | Assigned To Examiner |
| 2024-01-05 | Non-Final Action Written |
| 2024-01-05 | Non-Final Action E-Mailed |
| 2024-01-05 | Notification Of Non-Final Action E-Mailed |
| 2024-01-05 | Non-Final Action Written |
| 2024-01-05 | Non-Final Action E-Mailed |
| 2024-01-05 | Notification Of Non-Final Action E-Mailed |
| 2023-10-05 | Teas Change Of Owner Address Received |
| 2023-10-05 | Applicant/Correspondence Changes (Non-Responsive) Entered |
| 2023-10-05 | Teas Revoke/App/Change Addr Of Atty/Dom Rep Received |
| 2023-10-05 | Attorney/Dom.rep.revoked And/Or Appointed |
| 2023-10-05 | Teas Change Of Correspondence Received |
| 2023-05-05 | Notice Of Design Search Code E-Mailed |
| 2023-05-04 | New Application Office Supplied Data Entered |
| 2023-04-13 | New Application Entered |
Goods & services by class
Class 5 Pharmaceuticals & supplements
Pharmaceutical and therapeutic preparations in the nature of adaptable, targetable, titratable, and re-dosable medicines for use in gene therapy, gene editing, and gene silencing; pharmaceutical preparations for the treatment of genetic diseases and disorders
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 4 Jun 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.